TABLE 1.
Clinical M. tuberculosis isolates included in the study
| Geographic origin | No. (%) of isolates
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | Pan-susceptible | INHr | Mono-INHr | MDR | Resistant to indicated no. of drugs
|
||||
| 1 | 2 | 3 | 4 | ||||||
| Australia | 56 | 26 (46) | 29 (52) | 20 (36) | 4 (7) | 21 (38) | 6 (11) | 3 (5) | 0 |
| Colombia | 302 | 159 (53) | 133 (44) | 3 (1) | 128 (46) | 10 (3) | 32 (11) | 68 (23) | 33 (11) |
| India | 45 | 10 (21) | 22 (49) | 2 (4) | 16 (36) | 12 (27) | 12 (27) | 8 (17) | 3 (7) |
| Mexico | 197 | 73 (37) | 121 (61) | 43 (22) | 65 (33) | 46 (23) | 54 (26) | 15 (8) | 9 (5) |
| New York | 146 | 119 (82) | 22 (15) | 3 (2) | 18 (12) | 7 (5) | 8 (5) | 2 (1) | 10 (7) |
| Spain | 109 | 97 (89) | 11 (10) | 1 (1) | 9 (8) | 2 (2) | 6 (5) | 4 (4) | 0 |
| Texas | 156 | 91 (58) | 65 (13) | 30 (19) | 32 (21) | 30 (19) | 10 (7) | 8 (5) | 17 (11) |
| Total | 1011 | 575 (57) | 403 (40) | 102 (10) | 272 (27) | 128 (13) | 128 (13) | 108 (11) | 72 (7) |